• Kekkaku : [Tuberculosis] · Nov 2014

    [Considerations on uses of newly developed anti-tuberculosis drugs for multi-drug resistant tuberculosis].

    • Toru Mori, Kenji Ogawa, Eriko Shigeto, Tadao Shimao, Katsuhiro Suzuki, Kazunari Tsuyuguchi, Hideaki Nagai, Tomoshige Matsumoto, Satoshi Mitarai, and Takashi Yoshiyama.
    • Kekkaku. 2014 Nov 1; 89 (11): 813-5.

    AbstractWe, group of tuberculosis experts, made discussions over how to improve the quality of treatment of multidrug resistant tuberculosis using a newly developed anti-tuberculosis drug, and at the same time, how to prevent the disadvantages of the treated patients and also that of persons who would be infected with newly produced drug-resistant bacilli, by preventing the emergence of resistance to the new drug. A series of proposals are made.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…